메뉴 건너뛰기




Volumn 57, Issue 9, 2013, Pages 4097-4104

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: A systematic review with cohort analysis and meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CARBAPENEM; CLAVULANIC ACID; CLOFAZIMINE; ISONIAZID; LINEZOLID; MACROLIDE; THIORIDAZINE; TUBERCULOSTATIC AGENT;

EID: 84882391241     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00120-13     Document Type: Review
Times cited : (82)

References (55)
  • 5
    • 36048947771 scopus 로고    scopus 로고
    • Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
    • Kim H-R, Hwang SS, Kim HJ, Lee SM, Yoo C-G, Kim YW, Han SK, Shim Y-S, Yim J-J. 2007. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 45:1290-1295.
    • (2007) Clin. Infect. Dis. , vol.45 , pp. 1290-1295
    • Kim, H.-R.1    Hwang, S.S.2    Kim, H.J.3    Lee, S.M.4    Yoo, C.-G.5    Kim, Y.W.6    Han, S.K.7    Shim, Y.-S.8    Yim, J.-J.9
  • 10
    • 84858657770 scopus 로고    scopus 로고
    • Linezolid for the treatment of complicated drug-resistant tuberculosis: A systematic review and meta-analysis
    • Cox H, Ford N. 2012. Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 16:447-454.
    • (2012) Int. J. Tuberc. Lung Dis. , vol.16 , pp. 447-454
    • Cox, H.1    Ford, N.2
  • 12
    • 84872371975 scopus 로고    scopus 로고
    • Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: A systematic review and meta-analysis
    • Dey T, Brigden G, Cox H, Shubber Z, Cooke G, Ford N. 2013. Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 68: 284-293.
    • (2013) J. Antimicrob. Chemother. , vol.68 , pp. 284-293
    • Dey, T.1    Brigden, G.2    Cox, H.3    Shubber, Z.4    Cooke, G.5    Ford, N.6
  • 14
    • 1642448538 scopus 로고    scopus 로고
    • Using regression models in epidemiologic analysis, p 181-197
    • Oxford University Press, New York, NY
    • Rothman KJ. 2002. Using regression models in epidemiologic analysis, p 181-197. In Epidemiology: an introduction. Oxford University Press, New York, NY.
    • (2002) Epidemiology: An Introduction
    • Rothman, K.J.1
  • 16
    • 1642420994 scopus 로고    scopus 로고
    • A modified Poisson regression approach to prospective studies with binary data
    • Zou G. 2004. A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159:702-706.
    • (2004) Am. J. Epidemiol. , vol.159 , pp. 702-706
    • Zou, G.1
  • 17
    • 0003726404 scopus 로고
    • Sage University Paper Series on Quantitative Applications in the Social Sciences, no. 07-106. Sage, Thousand Oaks, CA
    • Menard S. 1995. Applied logistic regression analysis. Sage University Paper Series on Quantitative Applications in the Social Sciences, no. 07-106. Sage, Thousand Oaks, CA.
    • (1995) Applied Logistic Regression Analysis
    • Menard, S.1
  • 18
    • 33748314681 scopus 로고    scopus 로고
    • Object-oriented computation of sandwich estimators
    • Zeileis A. 2006. Object-oriented computation of sandwich estimators. J. Stat. Softw. 16:1-16. http://www.jstatsoft.org/v16/i09/.
    • (2006) J. Stat. Softw. , vol.16 , pp. 1-16
    • Zeileis, A.1
  • 19
    • 77958110812 scopus 로고    scopus 로고
    • Conducting meta-analyses in R with the metafor package
    • Viechtbauer W. 2010. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36:1-48. http://www.jstatsoft.org/v36/i03/.
    • (2010) J. Stat. Softw. , vol.36 , pp. 1-48
    • Viechtbauer, W.1
  • 20
    • 84889428993 scopus 로고    scopus 로고
    • Regression methods to detect publication and other bias in meta-analysis
    • Rothstein HR, Sutton AJ, Borenstein M (ed), John Wiley & Sons, Ltd, Chichester, United Kingdom
    • Sterne J, Egger M. 2005. Regression methods to detect publication and other bias in meta-analysis, p 99-110. In Rothstein HR, Sutton AJ, Borenstein M (ed), Publication bias in meta-analysis: prevention assessment and adjustments. John Wiley & Sons, Ltd, Chichester, United Kingdom.
    • (2005) Publication Bias in Meta-analysis: Prevention Assessment and Adjustments , pp. 99-110
    • Sterne, J.1    Egger, M.2
  • 25
    • 59349113030 scopus 로고    scopus 로고
    • Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis
    • Nam H-S, Koh W-J, Kwon OJ, Cho S-N, Shim TS. 2009. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis. Int. J. Antimicrob. Agents 33:92-93.
    • (2009) Int. J. Antimicrob. Agents , vol.33 , pp. 92-93
    • Nam, H.-S.1    Koh, W.-J.2    Kwon, O.J.3    Cho, S.-N.4    Shim, T.S.5
  • 27
    • 77952564621 scopus 로고    scopus 로고
    • Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
    • Anger HA, Dworkin F, Sharma S, Munsiff SS, Nilsen DM, Ahuja SD. 2010. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. J. Antimicrob. Chemother. 65:775-783.
    • (2010) J. Antimicrob. Chemother. , vol.65 , pp. 775-783
    • Anger, H.A.1    Dworkin, F.2    Sharma, S.3    Munsiff, S.S.4    Nilsen, D.M.5    Ahuja, S.D.6
  • 28
    • 77949777990 scopus 로고    scopus 로고
    • Increasing pathomorphism of pulmonary tuberculosis: An observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid?
    • Manfredi R, Nanetti A, Dal Monte P, Calza L. 2009. Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? Braz. J. Infect. Dis. 13:297-303.
    • (2009) Braz. J. Infect. Dis. , vol.13 , pp. 297-303
    • Manfredi, R.1    Nanetti, A.2    Dal Monte, P.3    Calza, L.4
  • 29
    • 73449138438 scopus 로고    scopus 로고
    • Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs
    • Sasse J, Teichmann D. 2009. Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs. Eur. Respir. Rev. 18:291-294.
    • (2009) Eur. Respir. Rev. , vol.18 , pp. 291-294
    • Sasse, J.1    Teichmann, D.2
  • 30
    • 79959274035 scopus 로고    scopus 로고
    • Linezolid in the treatment of multidrug-resistant/extensively drugresistant tuberculosis in paediatric patients: Experience of a paediatric infectious diseases unit
    • Kjöllerström P, Brito MJ, Gouveia C, Ferreira G, Varandas L. 2011. Linezolid in the treatment of multidrug-resistant/extensively drugresistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit. Scand. J. Infect. Dis. 43:556-559.
    • (2011) Scand. J. Infect. Dis. , vol.43 , pp. 556-559
    • Kjöllerström, P.1    Brito, M.J.2    Gouveia, C.3    Ferreira, G.4    Varandas, L.5
  • 31
    • 79959935423 scopus 로고    scopus 로고
    • Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB
    • Udwadia ZF, Sen T, Pinto LM. 2011. Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB. Recent Pat. Antiinfect. Drug Discov. 6:88-91.
    • (2011) Recent Pat. Antiinfect. Drug Discov. , vol.6 , pp. 88-91
    • Udwadia, Z.F.1    Sen, T.2    Pinto, L.M.3
  • 34
    • 84867387568 scopus 로고    scopus 로고
    • Clofazimine in the treatment of multidrug-resistant tuberculosis
    • Xu H-B, Jiang R-H, Xiao H-P. 2012. Clofazimine in the treatment of multidrug-resistant tuberculosis. Clin. Microbiol. Infect. 18:1104-1110.
    • (2012) Clin. Microbiol. Infect. , vol.18 , pp. 1104-1110
    • Xu, H.-B.1    Jiang, R.-H.2    Xiao, H.-P.3
  • 37
    • 84863177484 scopus 로고    scopus 로고
    • Linezolid in the treatment of MDRTB: A retrospective clinical study
    • Xu H-B, Jiang R-H, Li L, Xiao H-P. 2012. Linezolid in the treatment of MDRTB: a retrospective clinical study. Int. J. Tuberc. Lung Dis. 16:358-363.
    • (2012) Int. J. Tuberc. Lung Dis. , vol.16 , pp. 358-363
    • Xu, H.-B.1    Jiang, R.-H.2    Li, L.3    Xiao, H.-P.4
  • 38
    • 84870223120 scopus 로고    scopus 로고
    • Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children
    • Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS. 2012. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children. Int. J. Tuberc. Lung Dis. 16:1588-1593.
    • (2012) Int. J. Tuberc. Lung Dis. , vol.16 , pp. 1588-1593
    • Rose, P.C.1    Hallbauer, U.M.2    Seddon, J.A.3    Hesseling, A.C.4    Schaaf, H.S.5
  • 39
    • 84879026253 scopus 로고    scopus 로고
    • Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis? Antimicrob
    • Chang KC, Yew WW, Cheung SW, Leung CC, Tam CM, Chau CH, Wen PK, Chan RC. 2013. Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis? Antimicrob. Agents Chemother. 57:3445-3449.
    • (2013) Agents Chemother. , vol.57 , pp. 3445-3449
    • Chang, K.C.1    Yew, W.W.2    Cheung, S.W.3    Leung, C.C.4    Tam, C.M.5    Chau, C.H.6    Wen, P.K.7    Chan, R.C.8
  • 43
    • 84861172988 scopus 로고    scopus 로고
    • Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients
    • Koh W-J, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS. 2012. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J. Antimicrob. Chemother. 67:1503-1507.
    • (2012) J. Antimicrob. Chemother. , vol.67 , pp. 1503-1507
    • Koh, W.-J.1    Kang, Y.R.2    Jeon, K.3    Kwon, O.J.4    Lyu, J.5    Kim, W.S.6    Shim, T.S.7
  • 44
    • 1642351934 scopus 로고    scopus 로고
    • Mutant prevention concentration: Comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis
    • Rodríguez JC, Cebrián L, López M, Ruiz M, Jiménez I, Royo G. 2004. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. J. Antimicrob. Chemother. 53:441-444.
    • (2004) J. Antimicrob. Chemother. , vol.53 , pp. 441-444
    • Rodríguez, J.C.1    Cebrián, L.2    López, M.3    Ruiz, M.4    Jiménez, I.5    Royo, G.6
  • 45
    • 44449177016 scopus 로고    scopus 로고
    • In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years
    • Huang T-S, Liu Y-C, Sy C-L, Chen Y-S, Tu H-Z, Chen B-C. 2008. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob. Agents Chemother. 52:2226-2227.
    • (2008) Antimicrob. Agents Chemother. , vol.52 , pp. 2226-2227
    • Huang, T.-S.1    Liu, Y.-C.2    Sy, C.-L.3    Chen, Y.-S.4    Tu, H.-Z.5    Chen, B.-C.6
  • 48
    • 0020589878 scopus 로고
    • In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis
    • Cynamon MH, Palmer GS. 1983. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 24:429-431.
    • (1983) Antimicrob. Agents Chemother. , vol.24 , pp. 429-431
    • Cynamon, M.H.1    Palmer, G.S.2
  • 49
    • 0025829552 scopus 로고
    • Amoxicillinclavulanic acid for treating drug-resistant Mycobacterium tuberculosis
    • Nadler JP, Berger J, Nord JA, Cofsky R, Saxena M. 1991. Amoxicillinclavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest 99:1025-1026.
    • (1991) Chest , vol.99 , pp. 1025-1026
    • Nadler, J.P.1    Berger, J.2    Nord, J.A.3    Cofsky, R.4    Saxena, M.5
  • 50
    • 0029018666 scopus 로고
    • Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis
    • Cavalieri SJ, Biehle JR, Sanders WE, Jr. 1995. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:1542-1545.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 1542-1545
    • Cavalieri, S.J.1    Biehle, J.R.2    Sanders Jr., W.E.3
  • 52
    • 0030462751 scopus 로고    scopus 로고
    • Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis
    • Amaral L, Kristiansen JE, Abebe LS, Millett W. 1996. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother. 38:1049-1053.
    • (1996) J. Antimicrob. Chemother. , vol.38 , pp. 1049-1053
    • Amaral, L.1    Kristiansen, J.E.2    Abebe, L.S.3    Millett, W.4
  • 53
    • 84859428822 scopus 로고    scopus 로고
    • Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections
    • Amaral L, Viveiros M. 2012. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections. Int. J. Antimicrob. Agents 39:376-380.
    • (2012) Int. J. Antimicrob. Agents , vol.39 , pp. 376-380
    • Amaral, L.1    Viveiros, M.2
  • 55
    • 84894079423 scopus 로고    scopus 로고
    • Role of clofazimine in the treatment of multidrug-resistant tuberculosis: A retrospective observational cohort assessment
    • 5 March. [Epub ahead of print.] doi:10.1093/jac/dks077
    • Xu HB, Jiang RH, Tang SJ, Li L, Xiao HP. 5 March 2012. Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment. J. Antimicrob. Chemother. [Epub ahead of print.] doi:10.1093/jac/dks077.
    • (2012) J. Antimicrob. Chemother
    • Xu, H.B.1    Jiang, R.H.2    Tang, S.J.3    Li, L.4    Xiao, H.P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.